Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

v3.20.2
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY - USD ($)
Series A Convertible Preferred Stock
Series B Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Non-controlling Interest
Total
Beginning balance - shares at Mar. 31, 2019 5,000,000 0 301,758,293        
Beginning balance - amount at Mar. 31, 2019 $ 500 $ 0 $ 30,177 $ 38,335,782 $ (41,223,445) $ 0 $ (2,856,986)
Issuance of shares under equity financing agreement - shares     11,482,721        
Issuance of shares under equity financing agreement - amount     $ 1,148 1,498,852     1,500,000
Issuance of common stock upon conversion - shares     3,000,000        
Issuance of common stock upon conversion - amount     $ 300 29,700     30,000
Beneficial conversion feature       58,548     58,548
Net loss         (795,270) 0 (795,270)
Ending balance - shares at Jun. 30, 2019 5,000,000 0 316,241,014        
Ending balance - amount at Jun. 30, 2019 $ 500 $ 0 $ 31,625 39,922,882 (42,018,715) 0 (2,063,708)
Beginning balance - shares at Mar. 31, 2019 5,000,000 0 301,758,293        
Beginning balance - amount at Mar. 31, 2019 $ 500 $ 0 $ 30,177 38,335,782 (41,223,445) 0 (2,856,986)
Issuance of common stock upon conversion - amount             170,000
Series B PS Dividends in kind issued - amount             275,400
Net loss             (1,651,981)
Ending balance - shares at Sep. 30, 2019 5,000,000 250 333,516,074        
Ending balance - amount at Sep. 30, 2019 $ 500 $ 0 $ 33,351 40,585,157 (42,875,426) 0 (2,256,418)
Beginning balance - shares at Jun. 30, 2019 5,000,000 0 316,241,014        
Beginning balance - amount at Jun. 30, 2019 $ 500 $ 0 $ 31,625 39,922,882 (42,018,715) 0 (2,063,708)
Issuance of shares under equity financing agreement - shares     3,275,060        
Issuance of shares under equity financing agreement - amount     $ 326 273,675     274,001
Issuance of common stock upon conversion - shares     14,000,000        
Issuance of common stock upon conversion - amount     $ 1,400 138,600     140,000
Purchase of Series B Preferred shares - shares   250          
Purchase of Series B Preferred shares - amount   $ 0   250,000     250,000
Net loss         (856,711)   (856,711)
Ending balance - shares at Sep. 30, 2019 5,000,000 250 333,516,074        
Ending balance - amount at Sep. 30, 2019 $ 500 $ 0 $ 33,351 40,585,157 (42,875,426) 0 (2,256,418)
Beginning balance - shares at Mar. 31, 2020 5,000,000 2,250 379,742,524        
Beginning balance - amount at Mar. 31, 2020 $ 500 $ 0 $ 37,975 43,533,242 (46,427,396) (82,101) (2,937,780)
Issuance of common stock upon conversion - shares     37,926,239        
Issuance of common stock upon conversion - amount     $ 3,793 222,644     226,437
Reclass of derivative liability upon conversion or redemption of related convertible debentures       205,000     205,000
Purchase of Series B Preferred shares - shares   1,250          
Purchase of Series B Preferred shares - amount   $ 0   1,250,000     1,250,000
Beneficial conversion feature       293,000 (293,000)   0
Dividends payable on Series B PS       (144,792)     (144,792)
Series B PS Dividends in kind issued - shares   50          
Series B PS Dividends in kind issued - amount   $ 0   56,458     56,458
Conversion of Series B PS to common stock - shares   (800) 33,569,730        
Conversion of Series B PS to common stock - amount   $ 0 $ 3,357 (3,357)     0
Common stock issued in Vista Warrant settlement - shares     17,500,000        
Common stock issued in Vista Warrant settlement - amout     $ 1,750 608,250     610,000
Reclass of warrant liability upon the cancellation of warrants under Vista Warrant settlement       90,000     90,000
Common stock issued to consultant - shares     1,250,000        
Common stock issued to consultant - amount     $ 125 61,125     61,250
Net loss         (477,072) (1,895) (478,967)
Ending balance - shares at Jun. 30, 2020 5,000,000 2,750 469,988,493        
Ending balance - amount at Jun. 30, 2020 $ 500 $ 0 $ 47,000 46,316,363 (47,342,260) (83,996) (1,062,394)
Beginning balance - shares at Mar. 31, 2020 5,000,000 2,250 379,742,524        
Beginning balance - amount at Mar. 31, 2020 $ 500 $ 0 $ 37,975 43,533,242 (46,427,396) (82,101) (2,937,780)
Issuance of common stock upon conversion - amount             336,437
Series B PS Dividends in kind issued - amount             134,443
Net loss             (1,068,846)
Ending balance - shares at Sep. 30, 2020 5,000,000 1,696 531,023,743        
Ending balance - amount at Sep. 30, 2020 $ 500 $ 0 $ 53,103 48,638,480 (48,821,413) (85,682) (215,012)
Beginning balance - shares at Jun. 30, 2020 5,000,000 2,750 469,988,493        
Beginning balance - amount at Jun. 30, 2020 $ 500 $ 0 $ 47,000 46,316,363 (47,342,260) (83,996) (1,062,394)
Issuance of common stock upon conversion - shares     1,014,001        
Issuance of common stock upon conversion - amount     $ 101 125,365     125,736
Purchase of Series B Preferred shares - shares   1,250          
Purchase of Series B Preferred shares - amount   $ 0   1,250,000     1,250,000
Beneficial conversion feature   $ 65   807,000 (807,000)   0
Dividends payable on Series B PS         (83,960)   (83,960)
Series B PS Dividends in kind issued - amount       77,984     77,984
Conversion of Series B PS to common stock - shares   (2,369) 58,521,249        
Conversion of Series B PS to common stock - amount   $ 0 $ 5,852 (5,852)     0
Common stock issued to consultant - shares     1,500,000        
Common stock issued to consultant - amount     $ 150 67,350     67,500
Net loss             (589,879)
Ending balance - shares at Sep. 30, 2020 5,000,000 1,696 531,023,743        
Ending balance - amount at Sep. 30, 2020 $ 500 $ 0 $ 53,103 $ 48,638,480 $ (48,821,413) $ (85,682) $ (215,012)